Proposed Regulations Create Framework for Vibrant Market with Exceptional Growth Prospects
Articles
EVIO, Inc. (EVIO) Obtains Expanded Accreditation to Conduct Pesticide, Residual Solvent Tests
EVIO, Inc. (OTCQB: EVIO) today announced that it has been granted an expansion to its accreditations from the Oregon Environmental Laboratory Accreditation Program.
WeedMD Launches Major Production Expansion with 610,000 Square Foot State-of-the-Art Greenhouse
WeedMD announces that it has entered into a definitive lease and purchase option agreement with Perfect Pick Farms Ltd., a large-scale modern greenhouse cultivator located in Strathroy, Ontario.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Partners with Stakeholders to Participate on Global Scale with DehydraTECH™
Amidst increasing awareness regarding cannabinoids and their potential health benefits, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is at the forefront of the booming cannabis industry with its patented delivery technology, DehydraTECH™.
Study: U.S. Marijuana Legalization Would Create a Million New Jobs, $132 Billion in Tax Revenue in First 8 Years - From Washington Post
Legalizing marijuana nationwide would create at least $132 billion in tax revenue and more than a million new jobs across the United States in the next decade, according to a new study.
Skinvisible, Inc. (SKVI) Maximizes Product Development Opportunities with Global Goals
Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI), continues to add significant value to its core business model with several key movements involving a proposed merger, new licensing agreements and formation of a specialized subsidiary.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Offers a Sweet Escape for Cannabis Users without Smoking or Sweeteners
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has pioneered an enabling technology that enhances the body’s absorption of cannabinoids.
Bitcoin’s Rise Solidifies the Intersection of Cannabis and Cryptocurrency
One area of the industry that appears to offer significant growth potential is the application of bitcoin and other cryptocurrencies to sectors of the economy, such as the cannabis industry.
Marijuana Company of America, Inc. (MCOA) Offers Promising Portfolio in Cannabis and Hemp
A new report from market analyst the Brightfield Group, featured in Forbes, estimates that global sales of cannabis will climb to $31.4 billion by 2021.
Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Aims to Enhance Opioid Analgesic Effects with Specific Cannabis Strain
On September 13, 2017, Cannevert Therapeutics Ltd. (“CTL”), the research arm of Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), filed a provisional patent for the use of a specific strain of cannabis to enhance the actions of opioid analgesics.
Marijuana Company of America (MCOA) Subsidiary Poised for Breakthrough with CBD-based Wellness Products
Marijuana Company of America, Inc. (OTC: MCOA), via its wholly-owned subsidiary hempSMART, is well positioned to take advantage of this industry growth through the development and marketing of innovative hemp-derived, CBD-based nutritional and wellness products.
Medical Cannabis Payment Solutions (REFG) Integrates Cryptocurrency Payment Options
Medical Cannabis Payment Solutions (OTC: REFG) announced that it will integrate First Bitcoin cryptocurrency (“$Weed”) with its StateSourced medical cannabis payment gateway service.
Purified Cannabinoids Open New Opportunities in Pain Management
In Canada, chronic pain affects 1.5 million people. As national and worldwide numbers in pain diagnoses continue to rise, innovators in the cannabis industry are developing promising therapies to address this growing market.
Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Providing Clinical Proof of Cannabis Efficiency
Through exacting scientific protocols, Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is about to radically change the understanding and applications of this millennia-old medicine.
BBC Capital - Meet Canada’s ‘weed sommelier’
Rade Kovacevic is a cannabis connoisseur. As the head of customer experience at Canopy Growth Corporation, a cannabis producer in Ontario, Canada, his job is to make sure his firm provides the highest quality marijuana. His company produces medicinal cannabis for patients across Canada, where recreational use is illegal but doctors can prescribe it to patients for medical purposes, such as pain management.